Get Involved

FEMAP research projects

FEMAP is involved in multiple research projects, and is working with a number of professionals in various academic disciplines. We also train undergraduate, graduate and postdoctoral students in clinical research involving mood and anxiety disorders.

Past Research

Past research has used functional brain imaging (with functional MRI scans) to study: connections between depression and self-injurious behavior, emotional regulation in mood disorders with and without regular marijuana use, exercise as a treatment of depression, and understanding stigma for youth with emotional concerns. We are investigating the ways in which mood problems, anxiety problems and substance abuse affect the “reward processing centers” of the brain.

Another research stream focuses on evaluating the FEMAP model, including intermediate and long-term assessments alongside qualitative studies on patient experiences. A long-term study evaluating those who had treatment at FEMAP found a reduction in depressive and anxiety symptoms, improvement in quality of life satisfaction and functioning, and satisfaction with care after 1-2 years.

For more detailed information about each of our studies, as well as studies for which we are currently seeking participant volunteers, please see below.

Participate in Research

It is the expectation (not requirement) that FEMAP patients will volunteer to participate in studies of the nature, causes of and best way to serve our future patients. Only through such volunteerism will we be able to progress towards better care of individuals with mood and anxiety concerns. Explore our current studies below:

  • The Effects of Adolescent Smoking on Increased Risk for Mood and Anxiety Disorders: Exploration of Mesocorticolimbic Dysregulation in GABA and Glutamate Transmission
    • Evidence shows high rates of smoking among individuals with psychiatric disorders and a growing trend of adolescent nicotine use, underscoring the importance of understanding its neurodevelopmental effects. Our approach involves neuroimaging to explore nicotine’s impact on brain structure and function, particularly in patients with mood and anxiety disorders
  • Using the InnoWell Platform to optimize patient outcomes, health service monitoring and cross-organizational collaboration to enhance patient care
    • This study evaluates the implementation of the InnoWell Platform, originally from Australia but adapted for the Canadian London/Middlesex regions, to enhance personalized mental health care. Participants can track and monitor their mental health metrics over time through surveys with clinician support. We aim to assess how this innovative approach can enhance patient engagement and outcomes through our research.
  • Exploring novel uses of microbiota therapy for managing the side effects of psychiatric pharmaceutical interventions
    • Harnessing the power of good gut bacteria, our study investigates the potential of Akkermansia muciniphilia (AM), a key regulator of our metabolism, to address weight gain from psychiatric medications. AM has demonstrated improvements in insulin sensitivity and weight reduction in various chronic conditions. By focusing on the gut-brain access, we explore the potential of apple cider vinegar to promote AM as a non-pharmacological intervention in those with anxiety and mood disorders experiencing medication-induced weight gain.

If you are interested in participating in research, contact Mike, Research Coordinator at:

Phone: 519-646-6000 extension 65196